Company profile: Avivagen
1.1 - Company Overview
Company description
- Provider of health supplements for livestock, pets, and humans, including OxC-beta Livestock to support immune function and overall health without antibiotics; Vivamune Health Chews for dogs to support skin, coat, joint function, and overall health; and Beta Blend, a human supplement derived from oxidized beta carotene to support immune function and overall health.
Products and services
- Beta Blend: Oxidized beta carotene-derived supplement for humans that supports immune function and promotes overall health, delivering carotenoid-based nutrition targeted at maintaining wellness
- OxC-beta Livestock: Antibiotic-free, livestock-feed supplement that supports immune function and promotes better overall health without antibiotics, built for incorporation into livestock feeds
- Vivamune Health Chews: Dog-specific, chew-based supplement that supports healthy skin, coat, joint function, and overall health in canines, produced to promote comprehensive pet wellness
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avivagen
Bond Vet
HQ: United States
Website
- Description: Provider of veterinary services through a network of clinics, offering primary care (annual checkups, vaccinations, dental cleanings), urgent care for non-life-threatening conditions, walk-in visits, and surgical procedures including spays, neuters, orthopedic surgeries, and mass removals, supported by a mobile app for communication, scheduling, and storage of pet medical records.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bond Vet company profile →
Pathway Vet Alliance
HQ: United States
Website
- Description: Provider of Austin, Texas-based veterinary hospital ownership and management, operating a portfolio of veterinary practices and offering business support to clinics. Services include primary care, specialty care, emergency care, urgent care, surgery, and pet boarding and grooming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathway Vet Alliance company profile →
Eupraxia Pharmaceuticals
HQ: Canada
Website
- Description: Provider of locally delivered, extended-release drug candidates and delivery technology. Portfolio includes EP-104 for long-lasting symptom relief in knee osteoarthritis and eosinophilic esophagitis; Diffusphere polymer-based system for targeted, extended release with fewer side effects; EP-104GI for EoE focused on safety and efficacy in trials; and EP-104IAR for knee osteoarthritis pain with positive clinical results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eupraxia Pharmaceuticals company profile →
Global Stem Cell Technology
HQ: Belgium
Website
- Description: Provider of state-of-the-art veterinary stem cell products developed and produced for horses and dogs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Global Stem Cell Technology company profile →
Stratford Rx
HQ: United States
Website
- Description: Provider of companion animal products for the veterinary industry, offering a complete line of topical dermatology products, dosage form animal health supplements and feed supplements, with supplements manufactured with advanced patented and proprietary technologies for unique delivery and absorption.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stratford Rx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avivagen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avivagen
2.2 - Growth funds investing in similar companies to Avivagen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avivagen
4.2 - Public trading comparable groups for Avivagen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →